Incannex Healthcare
IXHL
4 hedge funds and large institutions have $167K invested in Incannex Healthcare in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
1,988% more capital invested
Capital invested by funds: $8K → $167K (+$159K)
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$80.6K |
| 2 |
FIA
FNY Investment Advisers
New York
|
+$75.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.62K |
IXHL Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Incannex Healthcare (IXHL) for Q3 2022, worth a combined $167K — up 1,988% from $8K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IXHL positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $80.6K. The largest seller was Morgan Stanley, cutting an estimated $2.62K.
- 4 institutional investors held Incannex Healthcare (IXHL) as of Q3 2022, up from 2 in Q2 2022.
- Funds reported $167K of Incannex Healthcare stock for Q3 2022, up 1,988% quarter-over-quarter.
- 2 funds opened new Incannex Healthcare positions in Q3 2022 and 0 closed out, a net change of +2 holders.
- The largest Incannex Healthcare buyer in Q3 2022 was Jane Street, an estimated $80.6K added.
- The largest Incannex Healthcare seller in Q3 2022 was Morgan Stanley, an estimated $2.62K sold.
Based on aggregated 13F filings for Q3 2022.